Spesolimab in Pyoderma Gangrenosum

Clinical trial NCT06092216 · TERMINATED

Trial details

NCT number: NCT06092216
Sponsor: Icahn School of Medicine at Mount Sinai
Status: TERMINATED
Phase: Phase 2
Study type: INTERVENTIONAL

Pyoderma Gangrenosum

Start date: 2023-09-23
Primary completion: 2025-01-14
Enrollment: 5

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.